Paper17548652
The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
Sheibanie AF and 6 others. J Immunol, 2007. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis. Papers, record 17548652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17548652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis | Major topic |
| Colon | Major topic |
| Dinoprostone | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Interleukin-17 | Major topic |
| Interleukin-23 | Major topic |
| Animals | |
| Anti-Ulcer Agents | |
| Cytokines | |
| Dendritic Cells | |
| Disease Models, Animal | |
| Interleukin-12 | |
| Interleukins | |
| Intestinal Mucosa | |
| Lipopolysaccharides | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Misoprostol | |
| Neutrophils | |
| T-Lymphocytes, Helper-Inducer | |
| Trinitrobenzenesulfonic Acid |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI 052306 | NIAID NIH HHS | United States | R01AI052306 | PubMed and NIH |
Source NIH RePORTER
Cited by136
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42619927 | Breaking the Barrier: Pro-inflammatory Stool from Infants with CHD Triggers Barrier Dysfunction within Intestinal Organoids. | Res Sq | 2026 | https://conductscience.org/library/papers/42619927 | PubMed |
| 42278445 | Potential Roles of Prostaglandins PGD2, PGJ2, and PGE2 in the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278445 | PubMed |
| 41942471 | Dissecting PGE2-driven inhibition of T cell activation using single-cell multi-omic and inflammatory bowel disease genetic association analysis. | Nat Commun | 2026 | https://conductscience.org/library/papers/41942471 | PubMed |
| 41252417 | PPI-based screening of hub genes related to sepsis migration/pyroptosis and immune infiltration analysis. | PLoS One | 2025 | https://conductscience.org/library/papers/41252417 | PubMed |
| 41055815 | Nanoencapsulated Syzygium aromaticum oil alleviates acetic acid-induced ulcerative colitis in rats by influencing critical redox, NF-κB/iNOS, and Keap1/Nrf2/HO-1 signaling pathways. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41055815 | PubMed |
| 40993946 | Fruitful Interventions: A Narrative Review Addressing the Emerging Role of Antioxidant Fruits in Combating IBD-Driven Colorectal Cancer. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/40993946 | PubMed |
| 40932933 | Critical signaling pathways in osteoclast differentiation and bone resorption: mechanisms and therapeutic implications for periprosthetic osteolysis. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40932933 | PubMed |
| 39627718 | Acid-sensing ion channel-1 contributes to the failure of myelin sheath regeneration following spinal cord injury by transcellular delivery of PGE2. | Cell Mol Biol Lett | 2024 | https://conductscience.org/library/papers/39627718 | PubMed |
| 39171684 | Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2. | Gut Microbes | 2024 | https://conductscience.org/library/papers/39171684 | PubMed |
| 39014047 | Causality of genetically determined blood metabolites on inflammatory bowel disease: a two-sample Mendelian randomization study. | Sci Rep | 2024 | https://conductscience.org/library/papers/39014047 | PubMed |
| 38817656 | Pathogenesis of chronic enteropathy associated with the SLCO2A1 gene: Hypotheses and conundrums. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/38817656 | PubMed |
| 38314173 | Insights Into Inflammatory Bowel Disease and Effects of Dietary Fatty Acid Intake With a Focus on Polyunsaturated Fatty Acids Using Preclinical Models. | J Can Assoc Gastroenterol | 2024 | https://conductscience.org/library/papers/38314173 | PubMed |
| 37891955 | Molecular Networking and Bioassay-Guided Preparation and Separation of Active Extract and Constituents from Vicia tenuifolia Roth. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37891955 | PubMed |
| 37868958 | Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment. | Front Immunol | 2023 | https://conductscience.org/library/papers/37868958 | PubMed |
| 37764683 | The Role of Lipids in the Regulation of Immune Responses. | Nutrients | 2023 | https://conductscience.org/library/papers/37764683 | PubMed |
| 37627616 | A Combination of Polymethoxyflavones from Citrus sinensis and Prenylflavonoids from Humulus lupulus Counteracts IL-1β-Induced Differentiated Caco-2 Cells Dysfunction via a Modulation of NF-κB/Nrf2 Activation. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37627616 | PubMed |
| 36613458 | Resolution Potential of Necrotic Cell Death Pathways. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613458 | PubMed |
| 36536643 | Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/36536643 | PubMed |
| 36364258 | Phenolic Profiles, Antioxidant and Anti-Inflammatory Activities of Hydrodistillation Wastewaters from Five Lamiaceae Species. | Molecules | 2022 | https://conductscience.org/library/papers/36364258 | PubMed |
| 36135048 | Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention. | Curr Oncol | 2022 | https://conductscience.org/library/papers/36135048 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| IL23A | 51561 | PubTator's text mining | https://conductscience.org/library/genes/51561 | NCBI Gene |
| IL27 | 246778 | PubTator's text mining | https://conductscience.org/library/genes/246778 | NCBI Gene |
| PTGER2 | 5732 | PubTator's text mining | https://conductscience.org/library/genes/5732 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17548652
GET https://conductscience.org/api/papers/v1/17548652/cited_by?page=2